Wealth Enhancement Advisory Services LLC Sells 14,829 Shares of Docusign Inc. $DOCU

Wealth Enhancement Advisory Services LLC lessened its stake in shares of Docusign Inc. (NASDAQ:DOCU) by 13.7% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 93,403 shares of the company’s stock after selling 14,829 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Docusign were worth $7,381,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Palogic Value Management L.P. raised its stake in shares of Docusign by 2.2% during the first quarter. Palogic Value Management L.P. now owns 5,438 shares of the company’s stock valued at $443,000 after acquiring an additional 117 shares in the last quarter. Wealthspire Advisors LLC raised its stake in Docusign by 1.9% in the first quarter. Wealthspire Advisors LLC now owns 6,579 shares of the company’s stock worth $536,000 after buying an additional 122 shares in the last quarter. Foundry Partners LLC raised its stake in Docusign by 1.5% in the first quarter. Foundry Partners LLC now owns 8,491 shares of the company’s stock worth $691,000 after buying an additional 125 shares in the last quarter. Bessemer Group Inc. raised its stake in Docusign by 27.5% in the first quarter. Bessemer Group Inc. now owns 602 shares of the company’s stock worth $49,000 after buying an additional 130 shares in the last quarter. Finally, Brooklyn Investment Group raised its stake in Docusign by 24.9% in the first quarter. Brooklyn Investment Group now owns 702 shares of the company’s stock worth $57,000 after buying an additional 140 shares in the last quarter. Institutional investors own 77.64% of the company’s stock.

Docusign Price Performance

Shares of DOCU opened at $84.82 on Wednesday. The firm has a market capitalization of $17.06 billion, a PE ratio of 63.77, a price-to-earnings-growth ratio of 4.45 and a beta of 1.02. Docusign Inc. has a 1-year low of $58.28 and a 1-year high of $107.86. The company’s fifty day moving average price is $76.74 and its 200-day moving average price is $79.35.

Docusign (NASDAQ:DOCU) last announced its quarterly earnings data on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, beating analysts’ consensus estimates of $0.84 by $0.08. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The firm had revenue of $800.64 million for the quarter, compared to analyst estimates of $780.35 million. During the same period in the previous year, the company earned $0.97 earnings per share. The business’s quarterly revenue was up 8.8% compared to the same quarter last year. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, research analysts anticipate that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign declared that its board has authorized a share buyback program on Thursday, June 5th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the company to buy up to 6.6% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s board believes its stock is undervalued.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on DOCU shares. Piper Sandler boosted their price objective on shares of Docusign from $85.00 to $90.00 and gave the stock a “neutral” rating in a research note on Friday, September 5th. Wedbush reduced their price objective on shares of Docusign from $100.00 to $85.00 and set a “neutral” rating for the company in a research note on Thursday, June 12th. Evercore ISI boosted their price objective on shares of Docusign from $90.00 to $92.00 and gave the stock an “in-line” rating in a research note on Friday, September 5th. Royal Bank Of Canada boosted their price objective on shares of Docusign from $90.00 to $95.00 and gave the stock a “sector perform” rating in a research note on Friday, September 5th. Finally, Wall Street Zen raised shares of Docusign from a “hold” rating to a “buy” rating in a research note on Saturday, September 13th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and fourteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $94.14.

Insider Activity

In other Docusign news, CEO Allan C. Thygesen sold 40,000 shares of the stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $77.51, for a total value of $3,100,400.00. Following the completion of the sale, the chief executive officer owned 143,983 shares in the company, valued at approximately $11,160,122.33. This represents a 21.74% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Blake Jeffrey Grayson sold 9,509 shares of the stock in a transaction dated Wednesday, September 17th. The shares were sold at an average price of $83.10, for a total transaction of $790,197.90. Following the completion of the sale, the chief financial officer owned 112,160 shares of the company’s stock, valued at approximately $9,320,496. The trade was a 7.82% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 82,533 shares of company stock worth $6,598,028. Company insiders own 1.66% of the company’s stock.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.